Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease -- White et al. 54 (11): 4611 Data Supplement - Supplemental material -- Antimicrobial Agents and Chemotherapy

Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease
Antimicrob. Agents Chemother. White et al. 54: 4611

Supplemental material

Files in this Data Supplement:

Supplemental file 1 - Table S1, in vitro pharmacology test results for BI 201335. Table S2, second experiment to determine combination indices for BI 201335 and alpha interferon combinations. Table S3, two additional experiments to determine combination indices for BI 201335 and ribavirin combinations.
Zipped PDF file, 78K.